Figure 1.
PFS and OS from randomization. Kaplan-Meier curves of PFS and OS in the intention-to-treat population by trial arm (A) and by TTP1 (B), as well as in the subgroup with TTP1 of >48 months by trial arm (C).
PFS and OS from randomization. Kaplan-Meier curves of PFS and OS in the intention-to-treat population by trial arm (A) and by TTP1 (B), as well as in the subgroup with TTP1 of >48 months by trial arm (C).
